|Dr. Brian Brooks (National Eye Institute - Bethesda, MD)|
|Dr. Robert Williams (University of Tennessee Health Science Center - Memphis, TN)|
Dr. Brian Brooks of the National Eye Institute discusses how gene therapy using the enzyme, RPE65, delivered short-term vision benefit to those afflicted with Leber Congenital Amaurosis.
Then, the University of Tennessee Health Science Center's Dr. Robert Williams talks about cellular and genomic processes that initiate glaucoma and an award he has received from Research to Prevent Blindness.
5/23/2015 Podcast (Click Image Below)